Literature DB >> 33315137

[The first oral LHRH antagonist-results of the HERO study].

Kurt Miller1.   

Abstract

Entities:  

Year:  2020        PMID： 33315137     DOI： 10.1007/s00120-020-01408-1

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  1 in total

1.  Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.

Authors:  Ajay S Behl; Lorie A Ellis; Dominic Pilon; Yongling Xiao; Patrick Lefebvre
Journal:  Am Health Drug Benefits       Date:  2017-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.